Tag Archives:Biomarker

Biomarker Europe Summit 2016

Organizer: GTCbio Start date: October 5th, 2016 End date: October 7th, 2016 GTCbio would like to invite you to attend our Biomarker Summit Europe 2016 on October 5-7, 2016 in Berlin, Germany! The summit will address the

Serum osteopontin as a novel biomarker for muscle regeneration in Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is an X-linked muscular disease, affecting boys in principle. It is caused by mutations in the gene coding for dystrophin, a membrane-related structural protein in skeletal and cardiac muscles. The lack of dystrophin

Special molecular mechanism makes CD147 an interesting drug target in cancer or autoimmune diseases

T cells are important players of the immune system, recognizing foreign or dangerous agents with their unique receptors. They defend the body from these agents either directly by killing or by recruiting or regulating other immune system

Neurophysiological biomarkers as a method to evaluate effects of drugs

When it comes to treatment of brain diseases not affecting the motor-system, drug development has proven difficult, because the majority of tests of drug-effects in animal experiments rely on changes in the behavior of the treated subject.

超灵敏检测和glycan analysis of a prostate cancer biomarker

In recent years we have seen an increased frequency of diagnosed prostate cancer (PCa) cases accompanied with an enhanced mortality worldwide. Symptoms of an early-stage PCa can be mild or even absent, thus there is an urgent

Osteopontin is a novel player and potential biomarker in hepatosplenic schistosomiasis mansoni

Schistosomiasis or bilharzia is a tropical disease caused by worms of the genus Schistosoma. Over 440 million people from 76 countries and territories are infected (Fig. 1). This water-based disease is considered the second most important parasitic

Milk fatty acids as possible biomarkers to diagnose hyperketonemia in early lactation

Aim of this study was to assess the potential of milk fatty acids (FA) as a diagnostic tool for hyperketonemia. Negative energy balance is a common phenomenon in the transition period in dairy cows. During this period,